Cannabis Science Announces Expansion Plans For MedBoxTM Medicine Dispensing System In Conjunction With Prescription Vending Machines Inc.

Cannabis Science, Inc., a U.S. biotech company developing pharmaceutical cannabis products, is pleased to provide an update for the rollout of its co-branded alliance with Prescription Vending Machines Inc. to distribute PVM's MedBoxTM.

MedBoxTM is a patented medicine delivery system that is used at pharmacies and other retail outlets where the identity of the individual purchasing medication needs to be verified as well as documenting compliance to statutory regulations. The MedBoxTM is patented in the U.S. and Canada, and referenced in Colorado's HB1043 for medical marijuana dispensary use.

MedBoxTM provides for individuals to conveniently purchase herbal medications and prescription medicines from the specialized vending machine. The system provides for the individual to be processed through a central database to be certain that the item being purchased has been legally authorized by an authorized medical professional. This is revolutionary in how individuals both access and obtain their herbal and prescription medicines, coupled with the traditional herbal medicine and pharmacy counters with staff to quickly verify dispensed medicine, if individuals so desire. This level of automation and regulation is a big technological step for herbal dispensaries and pharmacies.

Dr. Robert J. Melamede, the CEO and President of Cannabis Science Inc., said in a prepared statement, "This alliance with Prescription Vending Machines is a unique opportunity for Cannabis Science to synergistically market non-ingestible cannabis-based extracts used in topical creams, gels, and other formulations utilizing PVM's MedBoxTM machines. This will provide sources of revenue from licensing Cannabis Science medical marijuana topical extracts and formulations to dispensaries in conjunction with the machines. As well, PVM President, Vincent Mehdizadeh is assisting Cannabis Science to establish a foundation that will make the company's medical cannabis based topical extracts and formulations available worldwide for the treatment of cancers, pain management, and other ailments such as PTSD. We look forward to the project rollout and marketing programs launching in the coming weeks."